ProShare Advisors LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 204 filers reported holding IMMUNOGEN INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$761,681
-17.2%
47,995
-1.6%
0.00%
-33.3%
Q2 2023$920,083
+490.5%
48,759
+20.2%
0.00%
Q1 2023$155,808
-31.5%
40,575
-11.6%
0.00%
-100.0%
Q4 2022$227,580
+12.7%
45,883
+8.6%
0.00%0.0%
Q3 2022$202,000
+9.2%
42,233
+2.3%
0.00%0.0%
Q2 2022$185,000
-38.5%
41,294
-34.6%
0.00%0.0%
Q1 2022$301,000
-43.5%
63,123
-12.0%
0.00%0.0%
Q4 2021$533,000
+37.0%
71,750
+4.6%
0.00%0.0%
Q3 2021$389,000
-31.9%
68,587
-20.8%
0.00%
-50.0%
Q2 2021$571,000
-9.8%
86,616
+10.8%
0.00%0.0%
Q1 2021$633,000
+40.4%
78,178
+11.8%
0.00%0.0%
Q4 2020$451,000
+154.8%
69,896
+42.1%
0.00%
+100.0%
Q3 2020$177,000
-25.0%
49,190
-4.0%
0.00%0.0%
Q2 2020$236,000
+105.2%
51,218
+51.3%
0.00%0.0%
Q1 2020$115,000
-56.8%
33,846
-35.0%
0.00%0.0%
Q4 2019$266,000
+92.8%
52,031
-8.9%
0.00%0.0%
Q3 2019$138,000
+7.8%
57,096
-3.0%
0.00%0.0%
Q2 2019$128,000
-28.9%
58,850
-11.2%
0.00%0.0%
Q1 2019$180,000
-42.9%
66,255
+0.9%
0.00%
-50.0%
Q4 2018$315,000
-57.5%
65,660
-16.2%
0.00%
-60.0%
Q3 2018$742,000
+4.8%
78,333
+7.6%
0.01%0.0%
Q2 2018$708,000
-9.0%
72,790
-1.5%
0.01%0.0%
Q1 2018$778,000
+40.9%
73,914
-14.1%
0.01%
+25.0%
Q4 2017$552,000
+1871.4%
86,076
+536.1%
0.00%
Q4 2016$28,000
-83.5%
13,531
-78.7%
0.00%
-100.0%
Q3 2016$170,000
-26.4%
63,384
-15.6%
0.00%
-33.3%
Q2 2016$231,000
-63.8%
75,122
+0.2%
0.00%
-66.7%
Q1 2016$639,000
-42.9%
74,992
-9.1%
0.01%
-35.7%
Q4 2015$1,120,000
+56.4%
82,498
+10.7%
0.01%
+40.0%
Q3 2015$716,000
-37.6%
74,549
-6.5%
0.01%
-37.5%
Q2 2015$1,147,000
+49.2%
79,739
-7.2%
0.02%
+77.8%
Q1 2015$769,000
+67.2%
85,958
+14.1%
0.01%
+80.0%
Q4 2014$460,000
-44.6%
75,337
-3.9%
0.01%
-54.5%
Q3 2014$830,000
-25.4%
78,354
-16.6%
0.01%
-21.4%
Q2 2014$1,113,000
-50.7%
93,917
-37.9%
0.01%
-50.0%
Q1 2014$2,257,000
+251.0%
151,141
+244.9%
0.03%
+180.0%
Q4 2013$643,000
-54.7%
43,824
-47.4%
0.01%
-70.6%
Q3 2013$1,419,000
+21.6%
83,359
+18.5%
0.03%
+47.8%
Q2 2013$1,167,00070,3220.02%
Other shareholders
IMMUNOGEN INC shareholders Q4 2022
NameSharesValueWeighting ↓
Redmile Group, LLC 13,063,767$35,403,0001.04%
QVT Financial LP 1,375,900$3,442,0000.87%
Virtus ETF Advisers LLC 50,045$136,0000.29%
Fernwood Investment Management, LLC 187,000$507,0000.27%
PURA VIDA INVESTMENTS, LLC 524,600$1,422,0000.20%
Endurant Capital Management LP 184,440$500,0000.20%
Birchview Capital, LP 90,000$244,0000.15%
TWIN FOCUS CAPITAL PARTNERS, LLC 112,873$306,0000.14%
DLD Asset Management, LP 1,239,500$3,347,0000.12%
DLD Asset Management, LP 1,186,300$3,215,0000.12%
View complete list of IMMUNOGEN INC shareholders